{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T20:30:31Z","timestamp":1794688231386,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03760-4","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:54:21Z","timestamp":1767178461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deep learning-based predictive models for assessing the impact of clinical factors and second primary malignancy on survival in patients with colorectal cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Zhengkuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxue","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"3760_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"3760_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385. https:\/\/doi.org\/10.1001\/jama.2021.0106.","journal-title":"JAMA"},{"key":"3760_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"key":"3760_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14:89\u2013103. https:\/\/doi.org\/10.5114\/pg.2018.81072.","journal-title":"Prz Gastroenterol"},{"key":"3760_CR5","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41598-021-82248-7","volume":"11","author":"J Halamkova","year":"2021","unstructured":"Halamkova J, et al. Second primary malignancies in colorectal cancer patients. Sci Rep. 2021;11:2759. https:\/\/doi.org\/10.1038\/s41598-021-82248-7.","journal-title":"Sci Rep"},{"key":"3760_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6172670","volume":"2018","author":"Q Chen","year":"2018","unstructured":"Chen Q, et al. Do patients with second primary colorectal cancer hold the similar prognosis and therapeutic benefits as those with initial primary colorectal cancer? Biomed Res Int. 2018;2018:6172670. https:\/\/doi.org\/10.1155\/2018\/6172670.","journal-title":"Biomed Res Int"},{"key":"3760_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12876-023-02974-2","volume":"23","author":"YC Sun","year":"2023","unstructured":"Sun YC, et al. Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER program. BMC Gastroenterol. 2023;23:354. https:\/\/doi.org\/10.1186\/s12876-023-02974-2.","journal-title":"BMC Gastroenterol"},{"key":"3760_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/CEJ.0000000000000731","volume":"31","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. The incidence of second primary cancer in male and female patients with initial colorectal cancer: a SEER population-based study. Eur J Cancer Prev. 2022;31:430\u201341. https:\/\/doi.org\/10.1097\/CEJ.0000000000000731.","journal-title":"Eur J Cancer Prev"},{"key":"3760_CR9","doi-asserted-by":"publisher","first-page":"e644","DOI":"10.1634\/theoncologist.2019-0266","volume":"25","author":"H Jia","year":"2020","unstructured":"Jia H, Li Q, Yuan J, Sun X, Wu Z. Second primary malignancies in patients with colorectal cancer: a population-based analysis. Oncologist. 2020;25:e644\u201350. https:\/\/doi.org\/10.1634\/theoncologist.2019-0266.","journal-title":"Oncologist"},{"key":"3760_CR10","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/ijc.34638","volume":"153","author":"LA Liang","year":"2023","unstructured":"Liang LA, Tseng YJ, Tanaka LF, Klug SJ. Second primary cancer among 217702 colorectal cancer survivors: an analysis of national German cancer registry data. Int J Cancer. 2023;153:1459\u201371. https:\/\/doi.org\/10.1002\/ijc.34638.","journal-title":"Int J Cancer"},{"key":"3760_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2020.03.032","volume":"481","author":"R Cuocolo","year":"2020","unstructured":"Cuocolo R, Caruso M, Perillo T, Ugga L, Petretta M. Machine learning in oncology: a clinical appraisal. Cancer Lett. 2020;481:55\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2020.03.032.","journal-title":"Cancer Lett"},{"key":"3760_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s44230-023-00041-3","volume":"3","author":"A Yaqoob","year":"2023","unstructured":"Yaqoob A, Musheer Aziz R, verma NK. Applications and techniques of machine learning in cancer classification: a systematic review. Human-Centric Intell Syst. 2023;3:588\u2013615. https:\/\/doi.org\/10.1007\/s44230-023-00041-3.","journal-title":"Human-Centric Intell Syst"},{"key":"3760_CR13","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1016\/j.csbj.2021.10.006","volume":"19","author":"K Kourou","year":"2021","unstructured":"Kourou K, et al. Applied machine learning in cancer research: a systematic review for patient diagnosis, classification and prognosis. Comput Struct Biotechnol J. 2021;19:5546\u201355. https:\/\/doi.org\/10.1016\/j.csbj.2021.10.006.","journal-title":"Comput Struct Biotechnol J"},{"key":"3760_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9025470","volume":"2021","author":"AB Tufail","year":"2021","unstructured":"Tufail AB, et al. Deep learning in cancer diagnosis and prognosis prediction: a minireview on challenges, recent trends, and future directions. Comput Math Methods Med. 2021;2021:9025470. https:\/\/doi.org\/10.1155\/2021\/9025470.","journal-title":"Comput Math Methods Med"},{"key":"3760_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105458","volume":"145","author":"M Shehab","year":"2022","unstructured":"Shehab M, et al. Machine learning in medical applications: a review of state-of-the-art methods. Comput Biol Med. 2022;145:105458. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105458.","journal-title":"Comput Biol Med"},{"key":"3760_CR16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/bib\/bbaa043","volume":"22","author":"S Jin","year":"2021","unstructured":"Jin S, Zeng X, Xia F, Huang W, Liu X. Application of deep learning methods in biological networks. Brief Bioinform. 2021;22:1902\u201317. https:\/\/doi.org\/10.1093\/bib\/bbaa043.","journal-title":"Brief Bioinform"},{"key":"3760_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1200\/JCO.2010.31.8311","volume":"29","author":"LG Morris","year":"2011","unstructured":"Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011;29:739\u201346. https:\/\/doi.org\/10.1200\/JCO.2010.31.8311.","journal-title":"J Clin Oncol"},{"key":"3760_CR18","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2147\/JMDH.S410301","volume":"16","author":"B Zhang","year":"2023","unstructured":"Zhang B, Shi H, Wang H. Machine learning and AI in cancer prognosis, prediction, and treatment selection: a critical approach. J Multidiscip Healthc. 2023;16:1779\u201391. https:\/\/doi.org\/10.2147\/JMDH.S410301.","journal-title":"J Multidiscip Healthc"},{"key":"3760_CR19","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White MC, et al. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014;46:S7-15. https:\/\/doi.org\/10.1016\/j.amepre.2013.10.029.","journal-title":"Am J Prev Med"},{"key":"3760_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","volume":"13","author":"J Lian","year":"2020","unstructured":"Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020;13:151.","journal-title":"J Hematol Oncol"},{"key":"3760_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023;8:200.","journal-title":"Signal Transduct Target Ther"},{"key":"3760_CR22","doi-asserted-by":"publisher","first-page":"1700996","DOI":"10.1002\/adma.201700996","volume":"29","author":"G Song","year":"2017","unstructured":"Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater. 2017;29:1700996.","journal-title":"Adv Mater"},{"key":"3760_CR23","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/j.bjps.2021.05.043","volume":"74","author":"G Kungwengwe","year":"2021","unstructured":"Kungwengwe G, et al. Preoperative versus post-operative radiotherapy for extremity soft tissue sarcoma: a systematic review and meta-analysis of long-term survival. J Plast Reconstr Aesthet Surg. 2021;74:2443\u201357.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"3760_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41698-023-00353-4","volume":"7","author":"FA Zeineddine","year":"2023","unstructured":"Zeineddine FA, et al. Survival improvement for patients with metastatic colorectal cancer over twenty years. NPJ Precis Oncol. 2023;7:16.","journal-title":"NPJ Precis Oncol"},{"key":"3760_CR25","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/cancers14122928","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shen X, Chen G, Du J. Drug resistance in colorectal cancer: from mechanism to clinic. Cancers. 2022;14:2928.","journal-title":"Cancers"},{"key":"3760_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/0284186X.2020.1837945","volume":"60","author":"H Rumpold","year":"2021","unstructured":"Rumpold H, et al. Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort. Acta Oncol. 2021;60:180\u20136.","journal-title":"Acta Oncol"},{"key":"3760_CR27","doi-asserted-by":"publisher","unstructured":"Low EE, et al. Risk Factors for Early-Onset Colorectal Cancer. Gastroenterol. 2020;159:492\u2013501 e497. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.004","DOI":"10.1053\/j.gastro.2020.01.004"},{"key":"3760_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27175730.","journal-title":"Molecules"},{"key":"3760_CR29","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"JX Hu","year":"2021","unstructured":"Hu JX, et al. Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27:4298\u2013321. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4298.","journal-title":"World J Gastroenterol"},{"key":"3760_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5.","journal-title":"Lancet"},{"key":"3760_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34734","author":"LA Meneses-Urrea","year":"2024","unstructured":"Meneses-Urrea LA, et al. Colorectal and gastric cancer and its association with dietary patterns in Colombia. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34734.","journal-title":"Heliyon"},{"key":"3760_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2469521","volume":"2016","author":"DH Tak","year":"2016","unstructured":"Tak DH, Moon HS, Kang SH, Sung JK, Jeong HY. Prevalence and risk factors of gastric adenoma and gastric cancer in colorectal cancer patients. Gastroenterol Res Pract. 2016;2016:2469521. https:\/\/doi.org\/10.1155\/2016\/2469521.","journal-title":"Gastroenterol Res Pract"},{"key":"3760_CR33","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1158\/1055-9965.EPI-09-0241","volume":"18","author":"D Huo","year":"2009","unstructured":"Huo D, Hetzel JT, Roy H, Rubin DT. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiol Biomarkers Prev. 2009;18:1979\u201385. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-0241.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3760_CR34","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.2147\/OTT.S110595","volume":"9","author":"SH Ko","year":"2016","unstructured":"Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG. Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms. Onco Targets Ther. 2016;9:5611\u20137. https:\/\/doi.org\/10.2147\/OTT.S110595.","journal-title":"Onco Targets Ther"},{"key":"3760_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11892-024-01556-0","volume":"25","author":"L Nguyen","year":"2025","unstructured":"Nguyen L, Shanmugan S. A review article: the relationship between obesity and colorectal cancer. Curr Diabetes Rep. 2025;25:8.","journal-title":"Curr Diabetes Rep"},{"key":"3760_CR36","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.3390\/cancers13164169","volume":"13","author":"M Rivera-Izquierdo","year":"2021","unstructured":"Rivera-Izquierdo M, et al. Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients. Cancers. 2021;13:4169.","journal-title":"Cancers"},{"key":"3760_CR37","doi-asserted-by":"publisher","first-page":"1298865","DOI":"10.3389\/fsurg.2024.1298865","volume":"11","author":"T Tomminen","year":"2024","unstructured":"Tomminen T, et al. Surgical and oncological results after rectal resections with or without previous treatment for prostate cancer. Front Surg. 2024;11:1298865.","journal-title":"Front Surg"},{"key":"3760_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.eururo.2018.12.003","volume":"75","author":"R Matta","year":"2019","unstructured":"Matta R, et al. Pelvic complications after prostate cancer radiation therapy and their management: an international collaborative narrative review. Eur Urol. 2019;75:464\u201376.","journal-title":"Eur Urol"},{"key":"3760_CR39","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/JME-14-0203","volume":"54","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Bolton EC, Jones JO. Androgens and androgen receptor signaling in prostate tumorigenesis. J Mol Endocrinol. 2015;54:R15-29. https:\/\/doi.org\/10.1530\/JME-14-0203.","journal-title":"J Mol Endocrinol"},{"key":"3760_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.beem.2013.05.001","volume":"27","author":"M Grossmann","year":"2013","unstructured":"Grossmann M, Cheung AS, Zajac JD. Androgens and prostate cancer; pathogenesis and deprivation therapy. Best Pract Res Clin Endocrinol Metab. 2013;27:603\u201316. https:\/\/doi.org\/10.1016\/j.beem.2013.05.001.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3760_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10:63\u201389. https:\/\/doi.org\/10.14740\/wjon1191.","journal-title":"World J Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03760-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:55:25Z","timestamp":1770036925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03760-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3760"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03760-4","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Because de-identified data were sourced from the publicly available Surveillance, Epidemiology, and End Results (SEER) database (\n                      \n                      ), informed consent was unnecessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"175"}}